Skip to main content
Caplight Logo









Cura Therapeutics

Cura Therapeutics

Private
Montreal, QuebecHealthcare & Life Scienceshttps://www.curatherapeutics.com/

Last Round

Accelerator

Nov 25, 2025

Total Funding Raised

$125,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Cura Therapeutics is a biotechnology company developing multimodal immunotherapies to treat metastatic cancers, pathogen infections, and age-associated diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

immunotherapymultimodal immunotherapyimmuno-oncologybiologicsfusion proteinspharma partnershipsprotein engineeringcancer therapeuticsmetastatic cancerAI drug discoverypreclinical biotechdrug discovery platformrecombinant proteinssolid tumor therapytumor microenvironment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cura Therapeutics Comparables

Compare Cura Therapeutics with similar companies based on industry and business-model similarity.

Cura Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ability Biotherapeutics
73%
Xilio Therapeutics
71%
Synthekine
70%

Cura Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorNov 25, 2025
AcceleratorMar 6, 2025

Key People

Founding team and executive leadership

Claudia Penafuerte

Cofounder and CEO

Founding Team

Cura Therapeutics Investors

Notable investors and investment history

Cura Therapeutics investors
InvestorRounds
Ontario Bioscience Innovation OrganizationAccelerator
Capital BioVenturesAccelerator
FACITAccelerator, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 145% MoM.

  • May 2, 2025

    Monthly visitors grew 116% MoM.

Cura Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cura Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cura Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersMontreal, Quebec
Employee Range3
Year Founded2017
Last FundingNov 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?